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The prevalence of Stenotrophomonas maltophilia in cystic ¢brosis
(CF) patients has increased since the early 1980s, reaching over
30% in some centers [1]. The reasons for this are unclear, but
may relate to changes in laboratory reporting practices, culture
techniques [2], and the selective pressure exerted by antipseu-
domonal antimicrobials [3]. Although the clinical signi¢cance
of this bacterium for patients with CF is disputed, there have
been anecdotal reports of gradual clinical deterioration in
patients chronically colonized with bacterial numbers of
r105 CFU/mL over several years [4]. The use of selective
media has been shown to increase the isolation rates of S. mal-
tophilia from clinical and environmental samples [5,6]. The
introduction of blood agar containing imipenem for routine
sputum culture at one CF center in theUK saw the prevalence
of S. maltophilia increase to 16% from 8% the year before [2].
Unfortunately this study did not compare directly the sensi-
tivity of the selective medium with a non-selective medium.
For this reason, we studied the sensitivity of a selective med-
ium (VIA medium, incorporating vancomycin, imipenem
and amphotericin B as selective agents) [5] for isolating S. mal-
tophilia from sputum samples collected from childrenwith CF
in comparison to an existing in-house method that utilized an
imipenem disk placed upon bacitracin^chocolate agar (BC
medium).
Between April 1994 and January 1995, 814 sputum samples
from 87 of the 140 full-time patients who attended the Regio-
nal Paediatric Cystic Fibrosis Unit during the study period
were analyzed. Each sample was mixed with an equal volume
of a sputum homogenizing agent (Sputasol; Oxoid Ltd,
Basingstoke, UK) and 10 mL applied to half of aVIA medium
plate [5]. Brie£y, this consisted of a mannitol agar base (Mast
Laboratories, Bootle, UK) containing bromothymol blue as
an indicator (S. maltophilia does not produce acid from manni-
tol), to which 5mg/L of vancomycin (Eli Lilly, Basingstoke,
UK), 32mg/L of imipenem (MSD, Hoddesdon, UK) and 4
mg/L of amphotericin B (Bristol-Myers Squibb, Hounslow,
UK) were added as selective agents [5].The sputum/homoge-
nizer mixture was diluted 1: 50 with sterile water; 10 mL was
applied to the other half of theVIA plate, and 10 mL to bacitra-
cin (10 000U/L) chocolate (BC) medium. A10-mg imipenem
disk was also placed onto the surface of the BC agar. All plates
were incubated at 37 C in air for 48 h. Plates that exhibited no
growth at 48 h were incubated for a further 24 h.The number
of colonies growing onVIA medium was counted to give an
approximate number of CFU/mL. These colonies and any
exhibiting imipenem resistance on BC mediumwere subcul-
tured onto non-selective media for purity and identi¢ed using
the API 20NE system (bioMe¨rieux, Marcy l'Etoile, France)
according to the manufacturer's guidelines. Statistical analysis
of the results was performed using the chi-squared test.
The comparative performance of VIA medium and BC
medium for the detection of S. maltophilia is shown inTable1.
VIA medium detected a signi¢cantly greater number of sam-
ples that were positive for S. maltophilia than did BC medium
with an imipenem disk placed upon it. The relationship
between the colony count on VIA medium and successful
detection on BC medium is shown in Figure 1.VIA medium
was more sensitive than BC medium, particularly when the
number of CFU/mL in samples was below106.
Other carbapenem-resistant Gram-negative bacilli were
also isolated during the study, although they were clearly dis-
tinguishable from S. maltophilia by their appearance on VIA
medium. Eighty-nine samples (from16 patients) grew Pseudo-
monas aeruginosa, and 21 samples (two patients) grew Burkhol-
deria cepacia.
This study highlights the improved detection of S. maltophi-
lia from CF sputum samples usingVIA as a selective medium.
In the case of CF sputum, the use of VIA medium inhibits
most strains of P. aeruginosa, the most signi¢cant respiratory
pathogen in this patient group. Although 89 of the samples
(from 16 patients) grew imipenem-resistant P. aeruginosa, this
organism was easy to distinguish from S. maltophilia on VIA
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medium by its colonial appearances. The increased sensitivity
of VIA medium related to its ability to detect low numbers of
S. maltophilia more readily than BC medium (Figure 1). Of
those samples positive on BC medium, 96% were present at
r105 CFU/mL. Although the clinical signi¢cance of this
organism in CF is uncertain, it has been associated with clini-
cal deterioration in some patients, particularly if counts persis-
tently excede 106 CFU/mL [4,7]. Even at this level, BC
medium failed to grow S.maltophilia from10% of samples that
were positive onVIA medium (Figure 1).The increased sensi-
tivity of VIAmedium also allowed earlier detection of S. mal-
tophilia in patient samples. Three patients were positive for S.
maltophilia onVIAmedium for1^4months before the isolation
of S. maltophilia on BC medium. Indeed, since the end of the
study, the use of enterobacterial repetitive intergenic consen-
sus sequences for typing [8] has con¢rmed that a strain of S.
maltophilia isolated on BC medium had been isolated 3 years
earlier onVIA medium during the study period. These ¢nd-
ings suggest that patients may be colonized for months or even
years with S. maltophilia before the organism is detected with
conventional culture methods.The role of S. maltophilia in the
natural history of pulmonary disease in patients with CF
remains undetermined.VIAmediumwill be a valuable tool in
our attempts to understand the role of this emerging organism
in CF.
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Table 1 Comparative performance of VIA medium and BC medium for isolation of S. maltophilia from sputum samples taken from CF
patients
Samples BC BC± Total Patients BC BC± Total
VIA 106 129a 235 VIA 26 8a 34
VIA± 0 579 579 VIA± 0 53 53
Total 106 708 814 Total 26 61 87
aP< 0.0001.
Figure 1 Samples positive for S. maltophilia on VIA medium:
relationship between colony count and detection on BC
medium.
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